Enzobiotic is a combination of synbiotics and proteolytic enzymes and is medically approved to improve protein metabolism, which can benefit people with CKD and inflammatory bowel disease (IBD).

This is used in conditions such as chronic kidney disease (CKD) and inflammatory bowel disease (IBD).

The medicine will be administered to you by a healthcare professional in a hospital setting. It is usually administered in the vein (intravenous). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.

The common side effects that are experienced while you are on the treatment with enzobiotic are diarrhea, gas, abdominal bloating and headache. Report your doctor immediately, if you experience any allergic reaction and infections.

Some people may be allergic to probiotics, so it is important to talk to your doctor if you have a history of allergies. These have not been studied in children, so they are not recommended for use in children. It contains live bacteria, which may be unsafe for people with immune system disorders. If you have an immune system disorder, talk to your doctor before taking it.

Side effects can be amplified when alcohol is combined with other medications, including enzobiotics. Therefore, it is best to avoid alcohol while taking them. Consult your doctor if you are planning to get pregnant or think you may be pregnant or while you are breastfeeding.

Talk to your doctor before taking Enzobiotics if you have any allergies. If you experience any side effects while taking it, talk to your doctor. They can help you determine if the side effects are serious and need to be treated. Some people may be allergic to probiotics, so it is important to talk to your doctor if you have a history of allergies. It may increase the risk of infection, especially in people with a weakened immune system. They may not be safe for everyone. If you are pregnant, breastfeeding, or have any other health conditions, talk to your doctor before taking them.

1. Anita Saxena et al, Enzobiotics-A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial [Published date - Sep 2022], [Accessed date 23 june 2023] https://pubmed.ncbi.nlm.nih.gov/36145188/
2. Youssef Bennis et al, The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial, [Published date - Sep 2022], [Accessed date 23 June 2023], https://pubmed.ncbi.nlm.nih.gov/31109001/

The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details consult your doctor about your medical condition to know if you are eligible to receive this treatment.